NASDAQ & Dollar Stocks in 2022: XRTX/ XRTX.V, KAVL, SFET, IPA/ IPA.V, PBIO

There are a number of stocks that are possibly going to come on to the radars of investors through the course of the week and this article is going to give you a fairly good idea about some of those. At the end of the day, it is not possible for investors to keep track of all stocks which may find traction among investors, and hence, there is a necessity for a degree of selectivity. This article is going to give you a look into five NASDAQ-listed stocks that you may consider adding to your watch lists.

XORTX Therapeutics (NASDAQ:XRTX) (XRTX.V) – This morning the XORTX Therapeutics stock has been in the middle of a major rally and has managed to clock gains of as much as 20% amidst heavy interest. The biotech company saw its stock soar this morning after it reported that the results from a pharmacokinetics bridging study had been positive.

The company is involved in therapies for progressive kidney disease and announced this morning that the top-line results from the part 2 study of RX-OXY-101 had been positive. That resulted in the rally that was seen in the stock today. Investors could do well to add the stock to their watch lists.

Kaival Brands Innovations Group Inc (NASDAQ:KAVL) – had been in the news not too long ago for having signed a significant deal with the tobacco behemoth Philip Morris International.

Last month on July 25 the company announced that it had launched a custom branded self-contained e-vapor product named Veeba. The product had been launched in Canada and had come not long after the agreement had been reached with Phillip Morris.

IPA/Immunoprecise Antibodies Ltd. – (NASDAQ: IPA) (TSXV: IPA) – The stock has been witnessing a consistent uptrend over the past month with a gain of over 55%. Impressively, the stock is now trading well above its 50-Day and 200-Day moving averages of $4.30 and $5.10 respectively.

In the FY 2022, the Company achieved record revenues of $19.4 million, up 8.1% from $17.9 million in the fiscal year 2021 The Company achieved record revenues of $5.2 million for the three months ended April 30, 2022, an increase of 7.4% over the same period last year. The Company achieved an increase in CRO revenue (total revenue minus Talem asset out-licensing revenue) of 15.9% over the same period last year.

Safe-T Group Ltd (NASDAQ:SFET) – If you are looking into cybersecurity stocks at this point in time then it may be a good move to consider tracking the Safe-T Group Ltd stock. The company had come into focus back on August 17 when it announced that it was going to release its financial results for the second quarter that had ended on June 30, 2022 on August 31, 2022. The stock may come into focus in the lead-up to the date. The company will host a conference call on the same day.

Pressure BioSciences Inc (OTCMKTS:PBIO) – Lastly, it is the Pressure BioSciences Inc stock that may deserve some attention at this point. The company, which is involved in producing pressure-based instruments which can be deployed in several industries, announced on August 18 that it had gone into a sales, distribution, and manufacturing agreement with the firm Canopy CBD Farms LLC. Canopy is based out of Massachusetts and is involved in processing, distributing and manufacturing hemp based CBD products.